Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.31.1 (
micrococcal nuclease
)
2,818
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rat livers were disrupted in the
TMS
buffer (10 mM Tris-HCl, pH 7.6, 5 mM MgCl2, 0.25 M sucrose +70 microM beta-mercaptoethanol) and the nuclei were purified by sedimentation through 2.2 M sucrose with the same components as in
TMS
. Then the nuclei were resuspended and washed 3 times in
TMS
. After that the nuclei were resuspended to 1 mg DNA per ml in TM buffer (10 mM Tris-HCl, pH 7.6, 0.2 mM MgCl2) followed by centrifugation at low speed. About 60% of total nuclear DNP was recovered by this extraction. The protein/DNA ratio in the extracted chromatin fraction (DNPs) was about 1.1. The bulk of the non-extracted in TM residual chromatin fraction was released from the nuclear pellet after treatment with
micrococcal nuclease
. This matrix-associated chromatin fraction (DNPm) is significantly enriched in non-histone proteins as compared with the DNPs; hence the protein/DNA ratio of DNPm is at least two times higher than that of DNPs. The protein components of DNPs are represented by five histones containing negligible non-histone admixture. One of them was identified as protein A24, another--as non-dissociated from DNA in 0.6 M NaCl acid-soluble protein with m. w. of about 42,500. The possible structural features of these two distinguishable chromatin fractions are discussed.
...
PMID:[Protein composition of chromatin fractions differing in their attachment to nuclear structures at low ionic strength]. 711 12